Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.
Gregory A. Otterson, MD
Advertisement
Articles by Gregory A. Otterson, MD
Gregory A. Otterson, MD, discusses when to start treatment with immunotherapy in patients with non–small cell lung cancer.
Gregory A. Otterson, MD, discusses targetable biomarkers in non–small cell lung cancer.
Advertisement
Latest Updated Articles
Dr. Otterson on Targetable Biomarkers in Lung CancerPublished: March 20th 2020 | Updated:
Dr. Otterson on When to Start Immunotherapy in NSCLCPublished: April 7th 2020 | Updated:
Dr. Otterson on the Utility of Immunotherapy in NSCLCPublished: May 28th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5